Patents by Inventor Steve Lambert

Steve Lambert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240127367
    Abstract: A crop prediction system performs various machine learning operations to predict crop production and to identify a set of farming operations that, if performed, optimize crop production. The crop prediction system uses crop prediction models trained using various machine learning operations based on geographic and agronomic information. Responsive to receiving a request from a grower, the crop prediction system can access information representation of a portion of land corresponding to the request, such as the location of the land and corresponding weather conditions and soil composition. The crop prediction system applies one or more crop prediction models to the access information to predict a crop production and identify an optimized set of farming operations for the grower to perform.
    Type: Application
    Filed: August 25, 2023
    Publication date: April 18, 2024
    Inventors: David Patrick Perry, Geoffrey Albert von Maltzahn, Robert Berendes, Eric Michael Jeck, Barry Loyd Knight, Rachel Ariel Raymond, Ponsi Trivisvavet, Justin Y H Wong, Neal Hitesh Rajdev, Marc-Cedric Joseph Meunier, Casey James Leist, Pranav Ram Tadi, Andrea Lee Flaherty, Charles David Brummitt, Naveen Neil Sinha, Jordan Lambert, Jonathan Hennek, Carlos Becco, Mark Allen, Daniel Bachner, Fernando Derossi, Ewan Lamont, Rob Lowenthal, Dan Creagh, Steve Abramson, Ben Allen, Jyoti Shankar, Chris Moscardini, Jeremy Crane, David Weisman, Gerard Keating, Lauren Moores, William Pate
  • Patent number: 11591590
    Abstract: The present disclosure relates to the generation of an activated platelet product in which one or more of the presence or absence of clots, the timing of clot formation (if present), and/or the mechanical strength of clots (if present) is controlled by the presence or concentration of calcium ions during the activation process. In certain embodiments, the calcium ion concentration is controlled in the presence of pulsed electric fields or a chemical activator (e.g., thrombin) as part of the activation process.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: February 28, 2023
    Assignee: General Electric Company
    Inventors: Vasile Bogdan Neculaes, Andrew Soliz Torres, Steve Lambert Klopman
  • Publication number: 20200239868
    Abstract: The present disclosure relates to the generation of an activated platelet product in which one or more of the presence or absence of clots, the timing of clot formation (if present), and/or the mechanical strength of clots (if present) is controlled by the presence or concentration of calcium ions during the activation process. In certain embodiments, the calcium ion concentration is controlled in the presence of pulsed electric fields or a chemical activator (e.g., thrombin) as part of the activation process.
    Type: Application
    Filed: April 16, 2020
    Publication date: July 30, 2020
    Inventors: Vasile Bogdan Neculaes, Andrew Soliz Torres, Steve Lambert Klopman
  • Patent number: 10633645
    Abstract: The present disclosure relates to the generation of an activated platelet product in which one or more of the presence or absence of clots, the timing of clot formation (if present), and/or the mechanical strength of clots (if present) is controlled by the presence or concentration of calcium ions during the activation process. In certain embodiments, the calcium ion concentration is controlled in the presence of pulsed electric fields or a chemical activator (e.g., thrombin) as part of the activation process.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: April 28, 2020
    Assignee: General Electric Company
    Inventors: Vasile Bogdan Neculaes, Andrew Soliz Torres, Steve Lambert Klopman
  • Publication number: 20170191052
    Abstract: The present disclosure relates to the generation of an activated platelet product in which one or more of the presence or absence of clots, the timing of clot formation (if present), and/or the mechanical strength of clots (if present) is controlled by the presence or concentration of calcium ions during the activation process. In certain embodiments, the calcium ion concentration is controlled in the presence of pulsed electric fields or a chemical activator (e.g., thrombin) as part of the activation process.
    Type: Application
    Filed: December 30, 2015
    Publication date: July 6, 2017
    Inventors: Vasile Bogdan Neculaes, Andrew Soliz Torres, Steve Lambert Klopman
  • Patent number: 7044541
    Abstract: A mid-mounted child's bicycle seat is disclosed for connecting to a bicycle behind the bicycle's handle bars and in front of the rider of the bicycle. The seat includes a seat body and a mounting system that is adapted to connect the seat body to a handlebar stem the bicycle. As the handlebars turn, the seat turns as well. The mounting system includes a mounting bracket that attaches to the handlebar stem and a mounting stem that extends outward from the mounting bracket, toward the rider of the bike, when the handlebars are facing forward. A bottom portion of the seat body connects to the mounting stem.
    Type: Grant
    Filed: October 10, 2003
    Date of Patent: May 16, 2006
    Inventors: Che Eissinger, Steve Lambert